March 8, 2024
Led by Dr. Suresh Mittal, Distinguished Professor of Virology in the Purdue University College of Veterinary Medicine, researchers are working on the development of a universal vaccine, one that would offer protection against all forms of influenza A that infect humans, regardless of the strain. Such a vaccine could eliminate the need to reformulate seasonal flu vaccines and provide the health care system with a jumpstart in combatting the next flu pandemic.
March 8, 2024
An advisory committee has been named to assist in the search for a successor to Dr. Willie Reed, who will step down June 30, after 17 years of leadership as dean of the Purdue University College of Veterinary Medicine and 25 total years of service to the university. A celebration of Dean Reed’s legacy will take place later this semester.
Purdue Launches Search for Successor to Pioneering Veterinary Medicine Dean Willie Reed Who will Step Down
March 8, 2024
Promising initial research could lead to more effective seasonal flu shots and ward against future pandemics
March 6, 2024
In the first experiment of its kind, Purdue University researchers treated canines diagnosed with cancer using chemotherapy to see if their response could lead to future treatment for human cancer patients. Chemoresistance, a patient's adverse reaction to chemotherapy, can lessen remission and survival time. Michael Childress, professor of comparative oncology in the College of Veterinary Medicine at Purdue University, said the dogs were chosen because they had diffuse large B-cell lymphoma. The condition mimics the cancer phenotypes or traits that would be needed when treating human cancer patients.
Purdue researchers see possible link with dog, human cancer treatments
March 5, 2024
Purdue University researchers are advancing a new technology that uses light waves to detect chemotherapy resistance in cancer cells into interventional clinical trials following positive results in a human pilot study. In February, David Nolte, a professor of physics at Purdue, and his colleagues published in Scientific Reports the results of a study of digital holographic optical coherence imaging (DHOCI) as a method to detect treatment resistance in tissue biopsy samples from humans and dogs given chemotherapy.
Biodynamic Imaging Shows Promise for Predicting Response to Chemotherapy
March 5, 2024
From studying animal science to elevating cancer research to helping health science investigators, Purdue University Department of Nutrition Science alumna Lynn Adams has always had one goal in mind: to make an impact. As a program director in the Outcomes Research Branch in the National Cancer Institute’s (NCI) Division of Cancer Control and Population Sciences, Adams helps researchers as they secure National Institutes of Health (NIH) funding to unlock new cancer knowledge and treatments.
FROM EXPLORING CELLS TO HELPING RESEARCHERS, HHS DISTINGUISHED ALUMNA ADVANCES CANCER RESEARCH
March 5, 2024
Tao and his associates have begun developing a patent-pending EV method for detecting proteins involved in drug absorption, distribution, metabolism and excretion (ADME). “If successful, this would be tremendously beneficial, especially for drug development companies,” Tao said. Tao and 10 co-authors from Purdue and St. Jude Children’s Research Hospital in Memphis, Tennessee, published the details of their method in the Proceedings of the National Academy of Sciences Nexus. The lead authors were Purdue alumnus Xiaofeng Wu and Menchus Quan, a Purdue doctoral student in biological sciences. According to Tao and his co-authors, the method may also lend itself to monitoring a patient’s drug metabolic performance and how drugs interact with each other. Both are key aspects of personalized medicine.
Purdue researchers explore noninvasive method for sampling drug response
March 5, 2024
Researchers led by Purdue University's Professor W. Andy Tao have made a groundbreaking advancement in personalized medicine through the development of a new application for extracellular vesicles (EVs). These biochemical messengers could soon play a crucial role in routinely sampling the body's reaction to various prescription drugs, potentially revolutionizing the way drug efficacy and interactions are monitored.
Purdue Team Develops Novel Method Using Extracellular Vesicles for Drug Response Monitoring
March 3, 2024
Have you ever wondered why some cancer treatments work for some patients but not for others? This question lies at the heart of a new study conducted by researchers at Purdue University. They’ve embarked on a mission to unlock the mysteries of chemoresistance — the phenomenon where cancer patients’ bodies resist the effects of chemotherapy.
A New Frontier in Cancer Treatment: Understanding Chemoresistance
March 1, 2024
Purdue University researchers have developed a patented therapeutic strategy for Lowe syndrome, an incurable and rare genetic disorder, by repurposing two drugs previously approved by the U.S. Food and Drug Administration for other conditions.
